(Q33180580)

23 July 2017

1 reference

title

Preclinical perspectives on platinum resistance (English)

1 reference

23 July 2017

1 reference

Kelland LR

1

1 reference

23 July 2017

1 January 2000

1 reference

23 July 2017

1 reference

23 July 2017

59 Suppl 4

1 reference

23 July 2017

1-8; discussion 37-8

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059004-00001

23 July 2017

0 references

cites work

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059004-00001

Strand-specific mismatch repair in mammalian cells

21 January 2018

1 reference

12 December 2020

A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system

1 reference

12 December 2020

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

1 reference

12 December 2020

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes

1 reference

12 December 2020

Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus

1 reference

12 December 2020

Fundamental studies with cisplatin

1 reference

12 December 2020

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

1 reference

12 December 2020

An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells

1 reference

12 December 2020

1 reference

12 December 2020

Solution structure of a cisplatin-induced DNA interstrand cross-link

1 reference

12 December 2020

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

12 December 2020

New developments and approaches in the platinum arena

1 reference

12 December 2020

Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer

1 reference

12 December 2020

Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione

1 reference

12 December 2020

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

1 reference

12 December 2020

DNA repair: enzymatic mechanisms and relevance to drug response

1 reference

12 December 2020

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

12 December 2020

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct

1 reference

12 December 2020

Activation of programmed cell death by anticancer agents: cisplatin as a model system

1 reference

12 December 2020

cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.

1 reference

12 December 2020

An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts

1 reference

12 December 2020

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

1 reference

12 December 2020

Cellular accumulation of the anticancer agent cisplatin: a review

1 reference

12 December 2020

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines

1 reference

12 December 2020

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line

1 reference

12 December 2020

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

1 reference

12 December 2020

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

12 December 2020

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

12 December 2020

Overexpression of metallothionein confers resistance to anticancer drugs.

1 reference

12 December 2020

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

12 December 2020

Recent insights into platinum drug resistance in cancer

1 reference

12 December 2020

Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance

1 reference

12 December 2020

DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity

1 reference

12 December 2020

Clinical perspectives on platinum resistance

1 reference

12 December 2020

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts

1 reference

12 December 2020

The role of DNA mismatch repair in platinum drug resistance

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

1 reference

12 December 2020

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

1 reference

12 December 2020

10.2165/00003495-200059004-00001

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10864225